Predicting chemo response in bladder cancer with gene mapping
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a new technology called spatial transcriptomics to study how bladder cancer tumors respond to chemotherapy before surgery. It aims to find patterns that predict which patients will benefit from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected of having muscle-invasive bladder cancer.
- You are scheduled to have a procedure called a transurethral resection to remove a sample of the tumor.
- You are at least 18 years old.
- You agree to let the researchers use a small piece of your tumor tissue for this study.
- You are willing to follow the study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well MRI scans can detect bladder cancer after chemotherapy, before surgery to remove the bladder. It may help doctors know if the chemo is working.
This trial compares three standard treatments for muscle-invasive bladder cancer: bladder removal surgery, radiation combined with chemotherapy, or both. It aims to find which approach works best while preserving quality of life.
This study uses a special PET/CT scan to see how far your bladder cancer has spread. The results may help doctors plan the best treatment for you.
This study looks at how chemotherapy given before bladder removal surgery changes the immune environment around the tumor. The goal is to see if these changes can help predict how well the treatment works, which could lead to better personalized care.
This trial studies how well certain markers in bladder cancer tissue can predict which patients will respond to chemotherapy given before surgery. This may help doctors choose the best treatment for each patient in the future.
This study looks at how well a standard chemotherapy given before surgery works for muscle-invasive bladder cancer. It aims to see if higher responses lead to better outcomes.
Hear when a new Muscle Invasive Bladder Cancer (MIBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.